Document is current

Article History

Received: 16 October 2018

Accepted: 1 March 2019

First Online: 25 March 2019

Authors’ information

: Paul T. Finger, MD, FACS has been an eye cancer specialist for 32 years. He has served as Chair, of the Ophthalmology Section of the American Joint Committee on Cancer to coordinate development of the staging system for conjunctival melanoma (and other cancers).Anna Pavlick, MD, MBA is a Professor of Medicine and Dermatology at New York University School of Medicine and co- Director, the NYU Melanoma Program.

: This retrospective clinical case series, reviewing the results of a new therapeutic intervention was approved by the Internal Review Board/Ethics Committee of The New York Eye Cancer Center. This study conforms to the Tenets of Helsinki and the Health Privacy and Portability Act of 1996.

: All patients have signed consent to have their medical information (details and images) used for research and publication.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.